XClose

UCL News

Home
Menu

Stomach cancer risk doubled by PPIs

30 September 2019

Proton pump inhibitors, a common medication used to treat acid reflux and heartburn, could double the risk of stomach cancer if used long-term, a study has found. Despite the risks, they have “good safety records for short-term use,” explains Professor Ian Wong (UCL Pharmacy).

Read: MSN